Biotherapy: Clinical Trials

3 trials for Biotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 enrolling by invitation. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Biotherapy: new trials by email Literature Review of Biotherapy trials Research Report on Biotherapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Respiratory Allergy on Response to Initiation of Biotherapy in Severe Asthma in Adult Severe Asthmatic Patients Followed at Poitiers University Hospital on Biotherapy
search for respiratory allergies - Severe Asthma, Biotherapy
Enrolling by invitationPoitiers University Hospital1002024-03-012025-04-08
Skin Adverse Reactions Occuring in Children Treated by Biotherapy for Chronic Inflammatory Disease
dermatological consultation - Biotherapy, Chronic Inflammatory Disease
CompletedCentre Hospitalier Universitaire, Amiens202020-03-122021-07-21
Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis
Anakinra, Tocilizumab, Adalimumab - Uveitis, Biotherapy
Phase 2CompletedAssistance Publique - Hôpitaux de Paris1122017-06-292025-09-16

Narrower conditions

Asthma (1)  ·  Gastrointestinal Diseases (1)  ·  Uveitis (1)

Broader conditions

Bronchial Diseases (1)  ·  Digestive System Diseases (1)  ·  Eye Diseases (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Respiratory Hypersensitivity (1)  ·  Respiratory Tract Diseases (1)  ·  Uveal Diseases (1)

Interventions

Adalimumab (1)  ·  Interleukin 1 Receptor Antagonist Protein (1)  ·  tocilizumab (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Poitiers University Hospital (1)

Countries

France (3)

Top investigators

David Saadoun, MD PHD (1)

Results publications

PMID 41643758

NIH funding

2016 (1)